30004111000001104: Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93673501000001118 Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93673601000001119 Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Bromocriptine mesilate	false	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Bromocriptine mesilate	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Bromocriptine	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Has basis of strength substance	Bromocriptine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet	Has AMP	True	Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93673501000001118	Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93673601000001119	Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module